• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: SENSEONICS INC. EVERSENSE TRANSMITTER; EVERSENSE CONTINUOUS GLUCOSE MONITOR SYSTEM

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

SENSEONICS INC. EVERSENSE TRANSMITTER; EVERSENSE CONTINUOUS GLUCOSE MONITOR SYSTEM Back to Search Results
Model Number 102208-600
Device Problem Imprecision (1307)
Patient Problems Hyperglycemia (1905); Nausea (1970); Blurred Vision (2137); Diabetic Ketoacidosis (2364)
Event Date 08/25/2023
Event Type  Injury  
Event Description
On (b)(6) 2023, senseonics was made aware of an adverse event where the user was admitted in hospital for diabetic ketoacidosis and hyperglycemia.On the day of event, when the user was at work she didn't feel well, and her bg measured at 6:05 am was 81 mg/dl.A few hours later, the user started having the symptoms of vomiting and blurry vision, which eventually led to the hospitalization where her bg was measured to be 681mg/dl around 9 am.After dms review it was confirmed that user didn't receive high glucose alerts at the times provided because the sg values didn't go above the high alert setting threshold.
 
Manufacturer Narrative
The manufacturer is currently performing an investigation and will provide the results with the supplemental report.
 
Manufacturer Narrative
The user reported a hospitalization event where the user stayed at the hospital for two days due to a hypoglycemia event.From an associated complaint of sensor inaccuracy, it was observed that the user's past calibration entries were consistent with situations where estimated values provided by the app are used instead of the user's true bg values, which was confirmed by the user.Entering anything other than a true bg value can disrupt the calibration and lead to significant deviations in the sensor readings displayed, and this can have an impact for several days after resuming normal calibration.The user received treatment at the hospital with insulin and fluids.B4.Date of this report updated to 27 october 2023.G3.Date received by manufacturer 6 october 2023.H6.Investigation findings updated to 213.H6.Investigation conclusions updated to 18, 19.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
EVERSENSE TRANSMITTER
Type of Device
EVERSENSE CONTINUOUS GLUCOSE MONITOR SYSTEM
Manufacturer (Section D)
SENSEONICS INC.
20451 seneca meadows parkway
germantown MD 20875 7005
Manufacturer (Section G)
SENSEONICS INC.
20451 seneca meadows parkway
germantown MD 20875 7005
Manufacturer Contact
vallikannu somasundaram
20451 seneca meadows parkway
germantown, MD 20875-7005
MDR Report Key17805351
MDR Text Key324107624
Report Number3009862700-2023-00182
Device Sequence Number1
Product Code QHJ
Combination Product (y/n)Y
Reporter Country CodeUS
PMA/PMN Number
P160048
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Consumer
Reporter Occupation Other
Type of Report Initial,Followup
Report Date 10/27/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received09/24/2023
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Lay User/Patient
Device Expiration Date08/18/2023
Device Model Number102208-600
Device Catalogue NumberFG-5900-01-001
Device Lot Number131426
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? No
Date Manufacturer Received10/06/2023
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured08/18/2022
Is the Device Single Use? No
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Hospitalization;
Patient Age48 YR
Patient SexFemale
-
-